Form4insider filings, from the source

SEC Form 4 · accession 0001140361-18-030802

HALOZYME THERAPEUTICS, INC. · HALO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Randal J Kirk
10% Owner
Period of report
Jun 27, 2018
Accepted (ET)
Jun 29, 2018 · 9:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 27, 2018S21,710$17.34D5,299,374Iby R.J. Kirk DOT
Common StockF1,F2Jun 28, 2018S52,094$16.99D5,247,280Iby R.J. Kirk DOT
Common StockF1,F2Jun 29, 2018S49,678$16.97D5,197,602Iby R.J. Kirk DOT
Common StockF1,F2Jun 27, 2018S31,795$17.34D3,945,650Iby Kapital Joe
Common StockF1,F2Jun 28, 2018S76,291$16.99D3,869,359Iby Kapital Joe
Common StockF1,F2Jun 29, 2018S72,753$16.97D3,796,606Iby Kapital Joe
Common StockF2holding———2,327,603Iby TSCP V
Common StockF2holding———290,460Iby JPK 2012
Common StockF2holding———46,701Iby Kellie L. Banks LTT
Common StockF2holding———354,654Iby JPK 2009
Common StockF2holding———354,653Iby MGK 2009
Common StockF2holding———2,235Iby ZSK 2009
Common StockF2holding———302,954Iby JPK 2008
Common StockF2holding———302,954Iby MGK 2008
Common StockF2holding———302,954Iby ZSK 2008
Common StockF2holding———11,317Iby Lotus Capital
Common StockF2holding———216,795Iby Staff 2001
Common StockF2holding———131,144Iby Sr Staff 2006
Common StockF2holding———65,572Iby Staff 2006
Common StockF2holding———21,858Iby Incentive 2006
Common Stockholding———3,562,388D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses